Dual-listed retirement village operator is asking shareholders to approve a resolution at its annual meeting to increase the director fee pool by more than 13%.
The raise will extend its cash runway while it seeks Medicare coverage and reimbursement.
Marsden Maritime Holdings shareholders overwhelmingly back $5.60 a share offer, uniting port and land assets under new consortium.
The company’s future dividend policy, which has been suspended since 2023, is based on cash generation.
Kiwi utilities-focused SaaS company says potential tariffs won't hurt its chances in the United States.
Listed transport heavyweight boosts revenue and profit while noting highly uncertain outlook.
The ASX-listed bioscience company posted a strong second half and its guidance for 2026 is bullish.
Hiving off a minority stake in Highbrook Business Park seen as a more attractive option than an equity issue.
Trade software-as-a-service business reported annual loss of $3.5m in FY25.
The cervical cancer screening device company's board warned in November it might not survive without raising more cash.